Klp Kapitalforvaltning As Akero Therapeutics, Inc. Transaction History
Klp Kapitalforvaltning As
- $19.9 Billion
- Q1 2025
A detailed history of Klp Kapitalforvaltning As transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 9,600 shares of AKRO stock, worth $431,232. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,600
Previous 11,000
12.73%
Holding current value
$431,232
Previous $306,000
26.8%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AKRO
# of Institutions
224Shares Held
68.5MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$308 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$271 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$251 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$235 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$194 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.09B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...